Team:Queens/Sponsors

From 2009.igem.org

(Difference between revisions)
Line 31: Line 31:
<div id="nav16d"><a href="https://2009.igem.org/Team:Queens/Sponsors"><img src="https://static.igem.org/mediawiki/2009/a/a0/QueensNavSponsors.png"></a></div>
<div id="nav16d"><a href="https://2009.igem.org/Team:Queens/Sponsors"><img src="https://static.igem.org/mediawiki/2009/a/a0/QueensNavSponsors.png"></a></div>
 +
 +
 +
<table style="background-color:#922334; position:relative; overflow:auto; left:200px; top:-215px; width:750px">
<table style="background-color:#922334; position:relative; overflow:auto; left:200px; top:-215px; width:750px">
<tr>
<tr>
-
<td align="left">
+
<td align="center">
-
<p style="font-size:175%;font-family:corbel;color:#172C4E;font-weight:bold"><i>Team Background</i></p>
+
<img src="https://static.igem.org/mediawiki/2009/7/74/QueensSponsors.png">
-
<p style="font-size:120%;font-family:palatino linotype;color:#ECB528">
+
-
The Queen's Genetically Engineered Machine Team (QGEM for short), is a brand new team at Queen's University this year. We all hail from different parts of the country and different educational backgrounds, with the exception of all being in the sciences. Our team is comprised of Biology, Life Sciences, Biochemical Engineering, and Engineering Chemistry students, along with an equally varied lineup of faculty advisors. While, we are new to iGEM this year, we are putting forth our best efforts with our project and are looking forward to presenting our results at the Jamboree this year.
+
-
</p>
+
</td>
</td>
</tr>
</tr>
-
<tr>
 
-
<td>
 
-
<br>
 
-
</td>
 
-
</tr>
 
-
<tr>
+
 
-
<td align="left">
+
-
<p style="font-size:175%;font-family:corbel;color:#172C4E;font-weight:bold"><i>Project Background</i></p>
+
-
<p style="font-size:120%;font-family:palatino linotype;color:#ECB528">
+
-
This year, the Queen’s iGEM team is exploring a new synthetic biology approach to treat atherosclerosis. The purpose of our project is to engineer <i>E.coli</i> cells to target and deliver drugs to the site of atherosclerotic plaques. This will be accomplished by designing a binding system that allows <i>E.coli</i> to adhere to plaque, an inducible effector system that produces and releases specific drugs to site of plaques, and a termination system that detaches the <i>E.coli</i> from the plaque and triggers self-destruction. For a more detailed explanation and breakdown please see our Project page.
+
-
</p>
+
-
</td>
+
-
</tr>
+
</table>
</table>
<br>
<br>
<br>
<br>
-
<center>
+
 
-
<p style="font-size:110%; font-family:corbel;color:#172C4E">
+
-
Last Updated: September 19, 2009 by Fr<sub>3</sub>P</p></center>
+
</body>
</body>

Revision as of 01:52, 17 October 2009








Last Updated: May 11, 2009 by Fr3P